PITTSBURGH One of the largest generic drug makers in the world has made some changes to its executive management.
Mylan announced Wednesday that it had promoted Heather Bresch to president. Bresch has worked for the company for 17 years, most recently as COO. Replacing her as COO is Rajiv Malik, who until recently served as head of global technical operations, overseeing research and development, manufacturing, supply chain and sourcing, quality and regulatory affairs.
The company also hired Timothy Sawyer as SVP strategic corporate development. In the role, Sawyer will report to Bresch, working with other members of senior management. Sawyer has worked in the generic drug industry for 16 years, until recently serving as EVP global generic sales and marketing for Barr Labs, recently acquired by Teva Pharmaceuticals.
“On behalf of myself and the board of directors at Mylan, we would like to personally congratulate Healther and Rajiv on their well-deserved promotions,” Mylan chairman and CEO Robert Coury said in a statement. “Their track record of delivering results and executing flawlessly, as well as their exemplary leadership skills, has earned them the right to these new roles.”